Article
Boston - Topical application of the small DNA fragment thymidine dinucleotide (pTT) can activate innate defense mechanisms in skin, which ultimately protect against development of skin cancers, according to a study by reasearchers at the Boston University School of Medicine.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.